Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer
出版年份 2017 全文链接
标题
Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer
作者
关键词
-
出版物
Nature Communications
Volume 8, Issue -, Pages 15921
出版商
Springer Nature
发表日期
2017-06-30
DOI
10.1038/ncomms15921
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Idelalisib
- (2015) Arpita Shah et al. ANNALS OF PHARMACOTHERAPY
- Pathological Axonal Death through a MAPK Cascade that Triggers a Local Energy Deficit
- (2015) Jing Yang et al. CELL
- Dysregulation of miR-212 Promotes Castration Resistance through hnRNPH1-Mediated Regulation of AR and AR-V7: Implications for Racial Disparity of Prostate Cancer
- (2015) Y. Yang et al. CLINICAL CANCER RESEARCH
- Identification and Functional Validation of Reciprocal microRNA-mRNA Pairings in African American Prostate Cancer Disparities
- (2015) B.-D. Wang et al. CLINICAL CANCER RESEARCH
- Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110 , for relapsed/refractory chronic lymphocytic leukemia
- (2014) J. R. Brown et al. BLOOD
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
- (2014) Ajay K. Gopal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alternative splicing in cancer: implications for biology and therapy
- (2014) J Chen et al. ONCOGENE
- A Novel Model to Combine Clinical and Pathway-Based Transcriptomic Information for the Prognosis Prediction of Breast Cancer
- (2014) Sijia Huang et al. PLoS Computational Biology
- Androgen Receptor Splice Variants in the Era of Enzalutamide and Abiraterone
- (2014) Mary Nakazawa et al. Hormones & Cancer
- Minireview: The Molecular and Genomic Basis for Prostate Cancer Health Disparities
- (2013) Isaac J. Powell et al. MOLECULAR ENDOCRINOLOGY
- Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
- (2013) H. Shi et al. Cancer Discovery
- High levels of p110δ PI3K expression in solid tumor cells suppress PTEN activity, generating cellular sensitivity to p110δ inhibitors through PTEN activation
- (2012) Niki Tzenaki et al. FASEB JOURNAL
- IsoformEx: isoform level gene expression estimation using weighted non-negative least squares from mRNA-Seq data
- (2011) Hyunsoo Kim et al. BMC BIOINFORMATICS
- Host-derived MMP-13 exhibits a protective role in lung metastasis of melanoma cells by local endostatin production
- (2011) H Fukuda et al. BRITISH JOURNAL OF CANCER
- Present and Future of PI3K Pathway Inhibition in Cancer: Perspectives and Limitations
- (2011) E. Ciraolo et al. CURRENT MEDICINAL CHEMISTRY
- CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignancies
- (2011) Jorge J Castillo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- p37δ is a new isoform of PI3K p110δ that increases cell proliferation and is overexpressed in tumors
- (2011) S Fransson et al. ONCOGENE
- PI3K Inhibitors in Cancer: Rationale and Serendipity Merge in the Clinic
- (2011) D. A. Fruman et al. Cancer Discovery
- CAL-101, a p110 selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability
- (2010) B. J. Lannutti et al. BLOOD
- Phosphatidylinositol 3-kinase- inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals
- (2010) S. E. M. Herman et al. BLOOD
- Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
- (2010) C. J. David et al. GENES & DEVELOPMENT
- Phosphoinositide 3-Kinase Pathway Activation in Phosphate and Tensin Homolog (PTEN)-deficient Prostate Cancer Cells Is Independent of Receptor Tyrosine Kinases and Mediated by the p110β and p110δ Catalytic Subunits
- (2010) Xinnong Jiang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The PI3K Pathway As Drug Target in Human Cancer
- (2010) Kevin D. Courtney et al. JOURNAL OF CLINICAL ONCOLOGY
- The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors
- (2010) Alex Berndt et al. Nature Chemical Biology
- The emerging mechanisms of isoform-specific PI3K signalling
- (2010) Bart Vanhaesebroeck et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Anti-tumor activity of splice-switching oligonucleotides
- (2010) John A. Bauman et al. NUCLEIC ACIDS RESEARCH
- Somatic Mutations in p85α Promote Tumorigenesis through Class IA PI3K Activation
- (2009) Bijay S. Jaiswal et al. CANCER CELL
- Alternative splicing and biological heterogeneity in prostate cancer
- (2009) Prabhakar Rajan et al. Nature Reviews Urology
- Explaining the Race Difference in Prostate Cancer Stage at Diagnosis
- (2008) B. A. Jones et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men
- (2008) T. A. Wallace et al. CANCER RESEARCH
- Pleiotropic Biological Activities of Alternatively Spliced TMPRSS2/ERG Fusion Gene Transcripts
- (2008) J. Wang et al. CANCER RESEARCH
- Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
- (2008) R. Hu et al. CANCER RESEARCH
- Targeting the Phosphoinositide 3-Kinase Isoform p110 Impairs Growth and Survival in Neuroblastoma Cells
- (2008) D. Boller et al. CLINICAL CANCER RESEARCH
- Delineation of TMPRSS2-ERG Splice Variants in Prostate Cancer
- (2008) Y. Hu et al. CLINICAL CANCER RESEARCH
- Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis
- (2008) Simon Evans et al. INTERNATIONAL JOURNAL OF CANCER
- Somatic mutations affect key pathways in lung adenocarcinoma
- (2008) Li Ding et al. NATURE
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
- (2008) Qun Pan et al. NATURE GENETICS
- Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression
- (2008) Aijing Sun et al. PROSTATE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More